AAAAAA
Results:
1-8
|
Results: 8
The impact of non-compliance on the cost-effectiveness of pharmaceuticals:A review of the literature
Authors:
Hughes, DA
Bagust, A
Haycox, A
Walley, T
Citation: Da. Hughes et al., The impact of non-compliance on the cost-effectiveness of pharmaceuticals:A review of the literature, HEALTH ECON, 10(7), 2001, pp. 601-615
Authors:
Bagust, A
Barraza-Llorens, M
Philips, Z
Citation: A. Bagust et al., Deriving a compound quality of life measure from the EORTC-QLQ-C30/LC13 instrument for use in economic evaluations of lung cancer clinical trials, EUR J CANC, 37(9), 2001, pp. 1081-1088
Authors:
Bagust, A
Walley, T
Citation: A. Bagust et T. Walley, An alternative to body mass index for standardizing body weight for stature, QJM-MON J A, 93(9), 2000, pp. 589-596
Authors:
Walley, T
Earl-Slater, A
Haycox, A
Bagust, A
Citation: T. Walley et al., An integrated national pharmaceutical policy for the United Kingdom?, BR MED J, 321(7275), 2000, pp. 1523-1526
Authors:
Bagust, A
Roberts, BL
Haycox, AR
Barrow, S
Citation: A. Bagust et al., The additional cost of obesity to the health service and the potential forresource savings from effective interventions, EUR J PUB H, 9(4), 1999, pp. 258-264
Authors:
Bagust, A
Place, M
Posnett, JW
Citation: A. Bagust et al., Dynamics of bed use in accommodating emergency admissions: stochastic simulation model, BR MED J, 319(7203), 1999, pp. 155-158
Authors:
Haycox, A
Bagust, A
Walley, T
Citation: A. Haycox et al., Importance of health economics must be recognised when trials are designed, BR MED J, 318(7199), 1999, pp. 1696-1697
Authors:
Haycox, A
Bagust, A
Walley, T
Citation: A. Haycox et al., Clinical guidelines - the hidden costs, BR MED J, 318(7180), 1999, pp. 391-393
Risultati:
1-8
|